May 12, 2020 / 11:13 AM / 23 days ago

BRIEF-Helius Medical Technologies Says FDA Granted Its Pons Device The Breakthrough Device Designation To Treat Gait Deficits Due To Symptoms Of Multiple Sclerosis

May 12 (Reuters) - Helius Medical Technologies Inc:

* HELIUS MEDICAL TECHNOLOGIES, INC. ANNOUNCES FDA HAS GRANTED THE PONS DEVICE BREAKTHROUGH DEVICE DESIGNATION FOR THE TREATMENT OF GAIT DEFICITS DUE TO SYMPTOMS OF MULTIPLE SCLEROSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below